Tag : COVID-19

Interview: Adopting Consumer Tech in Clinical Trials Will Pave the Way for Hybrid and Virtual Trials

Can we make virtual trials a reality? In order to succeed, we need to start now with adopting technologies more broadly. Wearables, sensors, and other devices promise to pave the way for a more virtual future and have an immediate impact on trials today, particularly in rare disease. Read our interview with Kemi Olugemo, M.D., Head of Neurology at Akcea Therapeutics for her expert predictions and advice.

Our Collective Response to COVID-19

We are all finding ways personally and professionally to meet the challenge posed by COVID-19.  Earlier this month, as the threat of COVID-19 was becoming increasingly clear, we at ArcheMedX took decisive action to protect our employees, their families, and our business partners by freezing all travel, ensuring we could work